Related News
Watchdog says Abbott milk cleared all quality tests
THE Chinese imported food watchdog said today they had so far not discovered any substandard issues with an Abbott infant formula sold on domestic markets after a report released by a Hong Kong-based research firm on the weekend put its quality under question.
The report by CER Research stated that a sample of Abbott Similac Stage 1 formula milk for 0-6 months old babies purchased from a Hong Kong local store failed to meet Chinese mainland protein standards for such products.
The research firm said it had sent the sample, along with those of some other foreign formula brands, to be tested by a top professional lab in Germany. The results showed sub-standard issues with all samples while Abbott Similac Stage 1 turned out the worse performer.
The firm also claimed that the Abbott formula contained casein levels exceeding mainland standards and said this could cause diarrhea, intestinal bleeding and kidney problems in babies alongside malnutrition.
Abbott China hit back by calling the report "utterly and deliberately misleading." The formula provider is readying legal actions against the research firm and has already sent its milk samples to be tested by an independent lab certified by professional international quality authorities.
Shanghai Entry-Exit Inspection and Quarantine Bureau said today none of the Abbott Similac Stage 1 batches imported to the mainland market had failed domestic standards.
The Similac Stage 1 products sold on the mainland market are produced in Singapore, New Zealand, the Netherlands and Spain and imported through the Shanghai port, according to Abbott. All batches ever imported have passed quarantine checks and gained certifications issued by the quarantine watchdog, Abbott China said.
Mainland standards rule that the whey-to-casein ratio in infant formulas should be 60 to 40 percent with whey content being no less than 60 percent. But this specific standard covering the ratio is not mentioned under the Hong Kong watchdog rules.
The report by CER Research stated that a sample of Abbott Similac Stage 1 formula milk for 0-6 months old babies purchased from a Hong Kong local store failed to meet Chinese mainland protein standards for such products.
The research firm said it had sent the sample, along with those of some other foreign formula brands, to be tested by a top professional lab in Germany. The results showed sub-standard issues with all samples while Abbott Similac Stage 1 turned out the worse performer.
The firm also claimed that the Abbott formula contained casein levels exceeding mainland standards and said this could cause diarrhea, intestinal bleeding and kidney problems in babies alongside malnutrition.
Abbott China hit back by calling the report "utterly and deliberately misleading." The formula provider is readying legal actions against the research firm and has already sent its milk samples to be tested by an independent lab certified by professional international quality authorities.
Shanghai Entry-Exit Inspection and Quarantine Bureau said today none of the Abbott Similac Stage 1 batches imported to the mainland market had failed domestic standards.
The Similac Stage 1 products sold on the mainland market are produced in Singapore, New Zealand, the Netherlands and Spain and imported through the Shanghai port, according to Abbott. All batches ever imported have passed quarantine checks and gained certifications issued by the quarantine watchdog, Abbott China said.
Mainland standards rule that the whey-to-casein ratio in infant formulas should be 60 to 40 percent with whey content being no less than 60 percent. But this specific standard covering the ratio is not mentioned under the Hong Kong watchdog rules.
- About Us
- |
- Terms of Use
- |
-
RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔$粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.